Clinical Trials Directory

Trials / Completed

CompletedNCT06580704

Lumbosacral Erector Spinae Plane Block Versus Psoas Muscle Compartment With Sciatic Nerve Block for Anesthesia for Unilateral Lower Limb Operations in Critically Ill Patients

Lumbosacral Erector Spinae Plane Block Versus Psoas Muscle Compartment With Sciatic Nerve Block for Anesthesia for Unilateral Lower Limb Operations in Critically Ill Patients: A Randomized Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Tanta University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study aims to compare lumbosacral erector spinae plane block and psoas muscle compartment with sciatic nerve block in unilateral lower limb operations in critically ill patients.

Detailed description

The lower limb surgeries are associated with acute postoperative pain and require long-term analgesia. Regional anesthesia is often used to prevent postoperative pain. Ultrasound-guided regional anesthetic approaches provide a simple intraoperative pathway that lowers pain scores with less impact on the respiratory or cardiovascular system. Psoas compartment block (PCB) is a peripheral regional technique of anesthesia, which provides a block of the main components of the lumbar plexus - the femoral, lateral cutaneous nerve of the femur and sciatic nerve. In combination with the sciatic nerve block, the psoas compartment block provides effective anesthesia of the entire lower extremity, with better hemodynamic stability. The erector Spinae plane block (ESPB) is a novel regional block technique primarily introduced in 2016 for managing severe neuropathic pain.

Conditions

Interventions

TypeNameDescription
DRUGLumbosacral Erector Spinae Plane BlockPatients will receive ultrasound-guided lumbosacral erector spinae plane block.
DRUGPsoas Muscle Compartment With Sciatic Nerve BlockPatients will receive ultrasound-guided psoas muscle compartment with sciatic nerve block.

Timeline

Start date
2024-08-31
Primary completion
2025-03-26
Completion
2025-03-26
First posted
2024-08-30
Last updated
2025-04-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06580704. Inclusion in this directory is not an endorsement.